# Clive Holmes

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/clive-holmes/

## Facts

| Field | Value |
| --- | --- |
| Citations | 52,200 |
| Field | Alzheimer's disease research and treatments |
| h-index | 81 |
| i10-index | 178 |
| Last Known Institution | University of Eastern Finland |
| OpenAlex ID | https://openalex.org/A5064532444 |
| ORCID iD | https://orcid.org/0000-0003-1999-6912 |
| Works | 372 |

## Researcher papers

- [Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease](https://scholariq.org/papers/genome-wide-association-study-identifies-variants-at-clu-and-picalm-associated/)
- [Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial](https://scholariq.org/papers/long-term-effects-of-a-42-immunisation-in-alzheimer-s-disease-follow-up-of-a/)
- [Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease](https://scholariq.org/papers/donepezil-and-memantine-for-moderate-to-severe-alzheimer-s-disease/)
- [Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease](https://scholariq.org/papers/genetic-evidence-implicates-the-immune-system-and-cholesterol-metabolism-in-the/)
- [Core outcome measures for interventions to prevent or slow the progress of dementia for people living with mild to moderate dementia: Systematic review and consensus recommendations](https://scholariq.org/papers/core-outcome-measures-for-interventions-to-prevent-or-slow-the-progress-of/)
- [Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology](https://scholariq.org/papers/clinical-practice-with-anti-dementia-drugs-a-revised-third-consensus-statement/)
- [Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores](https://scholariq.org/papers/common-variants-in-alzheimer-s-disease-and-risk-stratification-by-polygenic-risk/)
- [A novel Alzheimer disease locus located near the gene encoding tau protein](https://scholariq.org/papers/a-novel-alzheimer-disease-locus-located-near-the-gene-encoding-tau-protein/)
- [Drug repositioning for Alzheimer's disease](https://scholariq.org/papers/drug-repositioning-for-alzheimer-s-disease/)
- [Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)](https://scholariq.org/papers/evaluating-the-effects-of-the-novel-glp-1-analogue-liraglutide-in-alzheimer-s/)

## Researcher topics

- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Neuroinflammation and Neurodegeneration Mechanisms](https://scholariq.org/topics/neuroinflammation-and-neurodegeneration-mechanisms/)
- [Tryptophan and brain disorders](https://scholariq.org/topics/tryptophan-and-brain-disorders-2/)
- [Genetic Associations and Epidemiology](https://scholariq.org/topics/genetic-associations-and-epidemiology/)

## Researcher university

- [University of Eastern Finland](https://scholariq.org/institutions/university-of-eastern-finland/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.